Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R William Watson

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Treatment and Research Communications|September 10, 2021
Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancerLauren Brady, Jessica Carlsson, Anne-Marie Baird, et al.
The Prostate|April 3, 2018
Role of serum response factor expression in prostate cancer biochemical recurrenceMaria Prencipe, Aurelie Fabre, Thomas Brendan Murphy, et al.
BJU International|February 3, 2016
European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional studyRobert W Foley, Robert M Maweni, Laura Gorman, et al.
Analytical Chemistry|December 8, 2020
Prostate Cancer Diagnosis in the Clinic Using an 8-Protein Biomarker PanelAbby L Jones, Lasangi Dhanapala, Thaísa A Baldo, et al.
BMC Medical Informatics and Decision Making|July 5, 2020
A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohortAmirhossein Jalali, Robert W Foley, Robert M Maweni, et al.
European Urology Focus|April 27, 2023
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate CancerAgnieszka Krzyzanowska, Stephen Barron, Debra F Higgins, et al.
BJUI Compass|January 29, 2025
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancerAgnieszka Krzyzanowska, Debra F Higgins, Stephen Barron, et al.
Cancers|August 27, 2021
Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical ProstatectomyShirin Moghaddam, Amirhossein Jalali, Amanda O'Neill, et al.
Molecular Oncology|June 22, 2018
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancerKeefe Murphy, Brendan T Murphy, Susie Boyce, et al.
Nature Communications|September 6, 2017
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancerSvitlana Tyekucheva, Michaela Bowden, Clyde Bango, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Treatment and Research Communications|September 10, 2021
Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancerLauren Brady, Jessica Carlsson, Anne-Marie Baird, et al.
The Prostate|April 3, 2018
Role of serum response factor expression in prostate cancer biochemical recurrenceMaria Prencipe, Aurelie Fabre, Thomas Brendan Murphy, et al.
BJU International|February 3, 2016
European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional studyRobert W Foley, Robert M Maweni, Laura Gorman, et al.
Analytical Chemistry|December 8, 2020
Prostate Cancer Diagnosis in the Clinic Using an 8-Protein Biomarker PanelAbby L Jones, Lasangi Dhanapala, Thaísa A Baldo, et al.
BMC Medical Informatics and Decision Making|July 5, 2020
A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohortAmirhossein Jalali, Robert W Foley, Robert M Maweni, et al.
European Urology Focus|April 27, 2023
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate CancerAgnieszka Krzyzanowska, Stephen Barron, Debra F Higgins, et al.
BJUI Compass|January 29, 2025
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancerAgnieszka Krzyzanowska, Debra F Higgins, Stephen Barron, et al.
Cancers|August 27, 2021
Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical ProstatectomyShirin Moghaddam, Amirhossein Jalali, Amanda O'Neill, et al.
Molecular Oncology|June 22, 2018
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancerKeefe Murphy, Brendan T Murphy, Susie Boyce, et al.
Nature Communications|September 6, 2017
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancerSvitlana Tyekucheva, Michaela Bowden, Clyde Bango, et al.
Pageof 4